Skip to content
FIND A HEALTH VALLEY ACTOR

Flowbone SA concludes a CHF 2.1 million Seed round

Flowbone team

The EPFL spin-off, active in the field of bone regeneration, prepares its US market entry.   “With aging population, fractures resulting from osteoporosis will significantly increase. Since current osteoporosis drugs have only limited efficacy in the hip region, there is an urgent need for a complimentary, local, and simple procedure to build up bone mass…

Read More

A UNIGE team reveals how Hepatitis B could be cured

Unige Hepatite B

The swiss🇨🇭 researchers have deciphered the precise functioning of a protective mechanism that could lead to a potential post-infection treatment   The hepatitis B virus (HBV) is responsible for one of the most serious and common infectious diseases. Transmitted through biological fluids, it attacks the liver cells. The chronic form of the disease can lead…

Read More

Four Swiss🇨🇭 start-ups in the Top 18 European TechBio companies

Top 18 European Biotech startups

ONWARD, Haya Therapeutics, Retinai and Engimmune Therapeutics are in the top 18 Biotech companies in Europe according to investors. Stuck in the middle… raising funds can be hard for biotech start-ups… Biotech investors may not get the tech bit, while tech investors don’t get the bio bit. Sifted asked investors who ventured into the TechBio world…

Read More

Volumina Medical closes its Series A funding to develop Adipearl

Volumina Medical

Clinique La Prairie and Skyviews Life Science Ltd are among the new investors   Volumina Medical, a spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL) specializing in developing innovative biomaterials announced that it has raised an undisclosed amount in a Series A fundraising. Around 2 million women are diagnosed with breast cancer…

Read More

Three new buildings on the Biopôle site in Lausanne

Biopôle SA

Biopôle SA announces a new partnership with Edmond de Rothschild Real Estate SICAV for the construction of three new buildings dedicated to Life Sciences. The work will start in December 2022 in Épalinges.   This new 23,000-m2 complex, distributed over three buildings, will host up to 500 people and has been designed to house both…

Read More

iOnctura, EBAMed and Terapet awarded by the Fongit

Fongit Fund

Fongit, the Fondation Genevoise pour l’Innovation Technologique, has just announced the latest beneficiaries of the Fongit Innovation Fund (FIF). iOnctura is awarded a growth loan of CHF 400,000. EBAMed and Terapet receive each a seed loan of CHF 100,000.     The Fongit Innovation Fund The FIF is the instrument for fostering innovation and the…

Read More

Future of Health: 10 digital healthcare start-ups awarded

Future of Health Grant

EPFL Innovation Park and CSS present the 2022 cohort   The Future of Health Grant programme to support innovation in digital healthcare has been launched. The ten selected start-ups will benefit from funding and know-how to help them accelerate the development of their solutions. A whole ecosystem of partners and experts in digital healthcare is…

Read More

Nanolive SA closes a series C round at $22.2 million

Nanolive

After the successful closing of a US $22.2 million Series C equity financing, Nanolive announces the appointment of two extraordinary women to its board of directors: Dr. Deborah Birx and Mrs. Victoria Wang.   Nanolive, based in canton de Vaud (Switzerland), develops cutting edge state-of-the-art label-free live cell digital analytical solutions to provide researchers and…

Read More

Hedera Dx raises €14 million in seed funding

Hedera Dx

The Swiss companies wants to accelerate the adoption of liquid biopsies for cancer testing   Swiss techbio company Hedera Dx, based in Biopôle Lausanne and founded in 2021 by veteran healthcare entrepreneurs and executives, will be launching this fall a blood-based testing solution to profile cancer DNA circulating in the blood, helping patients access better…

Read More

Incepto raised €27 million

Incepto

The platform for artificial intelligence solutions applied to medical imaging, announces a €27 million round of financing. The goal: to treat one million patients in Europe per month by 2024.   Incepto, which has a branch office at the Biopôle Lausanne in Switzerland, has just raised €27 million in a financing round led by LBO…

Read More